Oceania Healthcare Limited (NZE:OCA)
New Zealand · Delayed Price · Currency is NZD 0.7550
+0.0150 (2.03%)
Jul 31, 2026, 5:00 PM NZST
Oceania Healthcare Cash Flow Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 0.12 | 30.42 | 31.47 | 15.45 | 61.13 |
Depreciation & Amortization | 23.02 | 21.37 | 18.43 | 17.27 | 18.18 |
Other Amortization | 0.73 | 0.78 | 0.56 | 0.65 | 0.44 |
Loss (Gain) From Sale of Assets | 3.61 | 1.13 | 5.76 | 1.29 | 1.15 |
Asset Writedown & Restructuring Costs | -42.45 | -63.96 | -50.96 | -9.19 | -58.21 |
Stock-Based Compensation | 1.07 | 0.83 | 0.46 | 0.68 | 0.68 |
Provision & Write-off of Bad Debts | 0.06 | 0.17 | 0.07 | 0.04 | 0.04 |
Other Operating Activities | 162.72 | 122.62 | 84.99 | 27.05 | 70.77 |
Change in Accounts Receivable | -2.14 | 6.86 | 3.09 | 5.64 | 13.11 |
Change in Accounts Payable | 22.62 | -9.92 | 9.48 | 11.33 | -1.76 |
Operating Cash Flow | 169.36 | 110.28 | 103.35 | 70.21 | 105.53 |
Operating Cash Flow Growth | 53.58% | 6.70% | 47.21% | -33.47% | -8.35% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -17.79 | -40.24 | -53.18 | -56.1 | -56.3 |
Sale of Property, Plant & Equipment | 52.01 | 32.1 | 20.32 | - | - |
Cash Acquisitions | - | - | - | -59.87 | -56.21 |
Sale (Purchase) of Real Estate | -67.64 | -73.75 | -128.38 | -103.63 | -106.32 |
Other Investing Activities | -11.57 | -18.43 | -17.98 | - | - |
Investing Cash Flow | -44.99 | -100.31 | -179.23 | -219.6 | -218.82 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 64.71 | 102.09 | 138.67 | 228.16 | 262.51 |
Total Debt Issued | 64.71 | 102.09 | 138.67 | 228.16 | 262.51 |
Long-Term Debt Repaid | -179.29 | -111.95 | -55.99 | -57.1 | -218.3 |
Total Debt Repaid | -179.29 | -111.95 | -55.99 | -57.1 | -218.3 |
Net Debt Issued (Repaid) | -114.57 | -9.86 | 82.68 | 171.07 | 44.22 |
Issuance of Common Stock | - | - | - | - | 20 |
Common Dividends Paid | - | - | -6.76 | -21.81 | -19.42 |
Other Financing Activities | -0.81 | - | - | -2.17 | -1.67 |
Financing Cash Flow | -115.38 | -9.86 | 75.92 | 147.09 | 43.13 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 9 | 0.1 | 0.05 | -2.31 | -70.16 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 151.57 | 70.04 | 50.17 | 14.1 | 49.23 |
Free Cash Flow Growth | 116.41% | 39.61% | 255.70% | -71.35% | -31.35% |
Free Cash Flow Margin | 56.39% | 26.69% | 18.90% | 5.71% | 21.30% |
Free Cash Flow Per Share | 0.21 | 0.10 | 0.07 | 0.02 | 0.07 |
Levered Free Cash Flow | 129.58 | 92.39 | 71.01 | -22.32 | 83.88 |
Unlevered Free Cash Flow | 141.86 | 105.41 | 77.82 | -16.62 | 87.48 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 26.48 | 36.88 | 37.99 | 14.37 | 10.85 |
Change in Working Capital | 20.48 | -3.06 | 12.57 | 16.97 | 11.35 |